Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nodular Sclerosis”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Testing effectiveness (Phase 2)WithdrawnNCT00881387
What this trial is testing

Rituximab, Gemcitabine, and Vinorelbine in Treating Patients With Hodgkin Lymphoma That Has Relapsed or Not Responded to Treatment

Who this might be right for
Lymphoma
University of Miami
Not applicableStudy completedNCT00305149
What this trial is testing

Risk Adapted Beacopp Regimen for Standard and High Risk Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin LymphomaNodular SclerosisMixed Cellularity+2 more
Rambam Health Care Campus 130
Large-scale testing (Phase 3)UnknownNCT00041210
What this trial is testing

Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Mount Vernon Cancer Centre at Mount Vernon Hospital 850
Testing effectiveness (Phase 2)Study completedNCT00070304
What this trial is testing

Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Children's Oncology Group 33
Testing effectiveness (Phase 2)Study completedNCT00255723
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 98
Testing effectiveness (Phase 2)Study completedNCT00002715
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Stanford University 50
Testing effectiveness (Phase 2)Ended earlyNCT00225173
What this trial is testing

Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease

Who this might be right for
Hodgkin Disease
Stanford University 45
Large-scale testing (Phase 3)Study completedNCT00025259
What this trial is testing

Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease

Who this might be right for
Childhood Lymphocyte-Depleted Classical Hodgkin LymphomaChildhood Mixed Cellularity Classical Hodgkin LymphomaChildhood Nodular Lymphocyte Predominant Hodgkin Lymphoma+5 more
Children's Oncology Group 1,734
Large-scale testing (Phase 3)Study completedNCT00003389
What this trial is testing

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Eastern Cooperative Oncology Group 854
Early research (Phase 1)Study completedNCT00439361
What this trial is testing

Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin LymphomaLymphoma
M.D. Anderson Cancer Center 14
Large-scale testing (Phase 3)Study completedNCT00302003
What this trial is testing

Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma

Who this might be right for
Childhood Favorable Prognosis Hodgkin LymphomaChildhood Lymphocyte Depletion Hodgkin LymphomaChildhood Mixed Cellularity Hodgkin Lymphoma+3 more
Children's Oncology Group 287
Not applicableStudy completedNCT06032754
What this trial is testing

PortoSinusoidal Vascular Diseases and Systemic Sclerosis

Who this might be right for
PSVD With or Without SSc
University Hospital, Caen 180
Testing effectiveness (Phase 2)Study completedNCT00132028
What this trial is testing

Vorinostat in Treating Patients With Relapsed or Refractory Advanced Hodgkin's Lymphoma

Who this might be right for
Adult Favorable Prognosis Hodgkin LymphomaAdult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin Lymphoma+5 more
National Cancer Institute (NCI) 27
Large-scale testing (Phase 3)Active Not RecruitingNCT03907488
What this trial is testing

Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma

Who this might be right for
Ann Arbor Stage III Hodgkin LymphomaAnn Arbor Stage III Lymphocyte-Depleted Classic Hodgkin LymphomaAnn Arbor Stage III Mixed Cellularity Classic Hodgkin Lymphoma+7 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00666484
What this trial is testing

Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma

Who this might be right for
LymphomaNeurotoxicity
University College, London 47
Testing effectiveness (Phase 2)UnknownNCT03077828
What this trial is testing

Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Lymphocyte-Rich Classical Hodgkin LymphomaRecurrent Lymphocyte-Depleted Classical Hodgkin LymphomaRecurrent Mixed Cellularity Classical Hodgkin Lymphoma+4 more
Northwestern University 43
Testing effectiveness (Phase 2)Study completedNCT00002461
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Montefiore Medical Center 35
Testing effectiveness (Phase 2)UnknownNCT01476410
What this trial is testing

Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+4 more
Northwestern University 48
Large-scale testing (Phase 3)Study completedNCT00049595
What this trial is testing

Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma

Who this might be right for
Lymphoma
European Organisation for Research and Treatment of Cancer - EORTC 552
Testing effectiveness (Phase 2)Study completedNCT00082966
What this trial is testing

Bortezomib in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Mixed Cellularity Hodgkin LymphomaAdult Nodular Sclerosis Hodgkin Lymphoma+1 more
National Cancer Institute (NCI) 43
Load More Results
994